For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Anadys Pharmaceuticals, Inc.

USPTO Granted Patents = 51

CIPO Patents = 3

EPO Patents = 13

Forward Citations = 311

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Stephen Evan Webber (17 out of 54 patents)

Peter Scott Dragovich (13 out of 54 patents)

Douglas Eric Murphy (12 out of 14 patents)

4. Chinh Viet Tran (11 out of 34 patents)

5. Frank Ruebsam (11 out of 13 patents)

6. Joseph R Lennox (9 out of 9 patents)

7. Erik J Rueden (9 out of 9 patents)

8. Gregory Jay Haley (9 out of 14 patents)

9. Alan X Xiang (8 out of 18 patents)

10. David J Kucera (8 out of 21 patents)

11. Devron R Averett (7 out of 24 patents)

12. Yuefen Zhou (7 out of 7 patents)

13. Liansheng Li (5 out of 115 patents)

14. C Richard Wobbe (5 out of 11 patents)

15. Zhongxiang Sun (4 out of 4 patents)

Core Competencies:

Deoxyribofuranose Compounds

Dosing Methods

Thiadiazine Compounds

TLR7 Ligands

Hepatitis C Treatment

Nucleosides

Antibacterial Compounds

Gene Expression Regulation

Fluorescence Anisotropy Screening

Pyridinone Compounds

Furanose Compounds

Antifungal Agents

51 patents: Sort by Forward Citations

1. 9227992 - Method of preparing deoxyribofuranose compounds (2016-01-05),

2. 9161946 - Dosing methods for treating disease (2015-10-20),

3. 9156832 - 5,6-dihydro-1H-pyridin-2-one compounds (2015-10-13),

4. 8883758 - 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof (2014-11-11),

5. 8829168 - Method of preparing deoxyribofuranose compounds (2014-09-09),

6. 8815847 - [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid (2014-08-26),

7. 8765741 - [object Object] (2014-07-01),

8. 8586578 - [object Object] (2013-11-19),

9. 8546602 - 5,6-D hydro-1H-pyridin-2-one compounds (2013-10-01),

10. 8236948 - 5,6-dihydro-1H-pyridin-2-one compounds (2012-08-07),

11. 8222404 - [1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound (2012-07-17),

12. 8211863 - Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus (2012-07-03),

13. 8193342 - Method for preparing furanose compounds (2012-06-05),

14. 8129368 - 5,6-dihydro-1H-pyridin-2-one compounds (2012-03-06),

15. 8101800 - [object Object] (2012-01-24),

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines for the treatment of viral diseases. With a strong emphasis on hepatitis C, Anadys aims to bring innovative therapies to improve the lives of patients worldwide. They are committed to scientific excellence and leveraging cutting-edge research to create breakthrough treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

51 Patents

#29 in South San Francisco, CA

#1,580 in California

#6,663 in US

#13,381 in the World

South San Francisco, CA, United States of America

Anadys Pharmaceuticals, Inc.

Forward Citations = 311

68 inventors:

Stephen Evan Webber (17 out of 54 patents)

Peter Scott Dragovich (13 out of 54 patents)

Douglas Eric Murphy (12 out of 14 patents)

4. Chinh Viet Tran (11 out of 34 patents)

5. Frank Ruebsam (11 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…